Canaccord raised the firm’s price target on Artivion (AORT) to $50 from $41 and keeps a Buy rating on the shares. The firm updated its model to reflect its market cap move.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AORT:
- Artivion price target raised to $46 from $40 at Stifel
- Artivion Amends Credit Agreement to Extend Loan Terms
- Artivion’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
- Artivion downgraded to Neutral from Buy at Ladenburg
- Artivion Inc. Reports Strong Q2 Earnings and Positive Outlook